Linklaters, Latham & Watkins, Clifford Chance and Ropes & Gray have all won mandates to advise on a £958 million takeover of U.K. pharmaceutical firm Vectura Group by private equity house The Carlyle Group. 

Vectura is a constituent of the FTSE 250 index, and specialises in the development of inhaled therapies for the treatment of respiratory diseases.